Injectable and topical neurotoxins in dermatology : Indications, adverse events, and controversies - 14/12/17
Abstract |
The use of neuromodulators for therapeutic and cosmetic indications has proven to be remarkably safe. While aesthetic and functional adverse events are uncommon, each anatomic region has its own set of risks of which the physician and patient must be aware before treatment. The therapeutic usages of botulinum toxins now include multiple specialties and multiple indications. New aesthetic indications have also developed, and there has been an increased utilization of combination therapies to combat the effects of global aging. In the second article in this continuing medical education series, we review the prevention and treatment of adverse events, therapeutic and novel aesthetic indications, controversies, and a brief overview of combination therapies.
Le texte complet de cet article est disponible en PDF.Key words : abobotulinum, adverse events, botulinum toxin, controversies, cosmetic uses, incobotulinum, neuromodulator, neurotoxin, onabotulinum, therapeutic uses
Plan
Funding sources: None. |
|
Conflicts of interest: None declared. |
|
Reprints not available from the authors. |
|
Date of release: June 2017 |
|
Expiration date: June 2020 |
Vol 76 - N° 6
P. 1027-1042 - juin 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?